Try our Advanced Search for more refined results
June 27, 2012
IN RE: CERTAIN CONSOLIDATED ZOLEDRONIC ACID CASES
Case Number:
2:12-cv-03967
Court:
Nature of Suit:
Judge:
Firms
- Axinn Veltrop
- Buchanan Ingersoll
- Connell Foley
- Cozen O'Connor
- Eckert Seamans
- Epstein Becker
- Flaster Greenberg
- Fleming Ruvoldt
- Fox Rothschild
- Goldberg Segalla
- Haug Partners
- Hunton Andrews
- Kasowitz Benson
- Kenyon & Kenyon
- K&L Gates
- Kramer Alberti
- McCarter & English
- Midlige Richter
- Panitch Schwarze
- Parker Ibrahim
- Patunas Law
- Rivkin Radler
- Robinson Miller
- Saiber LLC
- Schnader Harrison
- Windels Marx
Companies
- Akorn Inc.
- Allergan PLC
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Fresenius Kabi AG
- Gland Pharma Ltd.
- Hospira Inc.
- Novartis AG
- Par Pharmaceutical Cos. Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- Wockhardt USA LLC
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 14, 2016
Novartis, Actavis Settle Patent Infringement Suit
Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in New Jersey federal court on Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login